Embody
  • Get Started
  • Our Top Products
  • GLP-1 Science
  • What To Expect
  • Market Leading Cost
  • FAQ
  • Contact Us

Partner Pharmacies

Embody works with the fulfillment partners listed below. The partners shown are based on this site’s configured telehealth network.

A listing does not guarantee that every product or prescription is available in every state. Availability depends on the product, patient location, and current fulfillment requirements.

Central Drug Pharmacy

520 W La Habra BoulevardLa Habra, CA 90631
(562) 691-6754centraldrugsrx.com

Reported service area

California, Arizona, Alaska, Colorado, Connecticut, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Michigan, Minnesota, Montana, Missouri, North Carolina, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Utah, Virginia, Washington, Wisconsin, West Virginia. See States we serve.

Epiq Scripts

465 W President George Bush Highway, Suite 240Richardson, TX 75080
(214) 478-8564epiqscripts.com

Reported service area

Every state where this site is available. See States we serve.

Genesis Compounding

12278 Lone Peak Parkway, Suite 106Draper, UT 84020
(385) 279-4420genesiscompounding.com

Reported service area

Every state where this site is available. See States we serve.

OptioRx

3701 Commercial Avenue, Suite 14Northbrook, IL 60062
(630) 242-8969optiorx.com

Reported service area

Every state where this site is available. See States we serve.

ReshapeRx

8560 Katy Freeway, Suite 170Houston, TX 77024
(346) 251-8191reshapepharmacy.com

Reported service area

Washington, Montana, Wyoming, Utah, Colorado, Arizona, New Mexico, Texas, Oklahoma, Kansas, South Dakota, Iowa, Missouri, Louisiana, Wisconsin, Illinois, Tennessee, Georgia, Florida, Pennsylvania, New York. See States we serve.

States we serve

Embody is available in 50 states and Washington, D.C. The full list is on our States we serve page.

View states▾
  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • District of Columbia
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming

Whether a treatment is available to you also depends on clinician licensure and the fulfillment partner. Service areas are based on partner-provided licensing and availability information and may change. The applicable fulfillment partner must confirm availability in your state before fulfillment.

About compounded medications

Compounded medications are prepared for an individual patient based on a clinician’s prescription. Compounded drugs are not FDA approved, and the FDA does not review them for safety, effectiveness, or quality before they are marketed.

Questions about fulfillment?

You may ask your clinician about using another pharmacy. The pharmacy must be able to fill the prescription and dispense it in your state. Contact us at support@bloome.health if you need information about the partner handling your fulfillment.

← Back to Home

Embody
  • 1811 Silverside Road, Suite 260, Wilmington, DE 19180
  • Login

*The assessment made available on the Embody website does not create a doctor-patient relationship between the individual completing the assessment and Embody. Our affiliated network of independent, US-licensed providers, who adhere to rigorous medical protocols designed for patient safety, has established exclusionary criteria to determine if an individual does not qualify for GLP-1s. The answers an individual provides to the Embody assessment consequently determine if the individual is screened out of eligibility for GLP-1 medication, and a licensed clinician will meet with an individual after checkout to determine if they qualify for a prescription. Licensed clinicians retain the decision to prescribe compounded GLP-1s to patients.

All claims and benefits on this website refer to self-reported data from GLP-1 customers on a treatment plan that includes compounded GLP-1 medications and consultations with medical professionals. Customers reported their weight on their initial medical intake questionnaire every 3-4 weeks thereafter. Results may vary and be affected by an individual's adherence to the program and their clinician's recommendations. Compounded GLP-1s are produced in FDA-regulated facilities. Although these facilities are highly regulated, the medications are not FDA-approved or evaluated for safety, efficacy, or quality. The decision to use compounded drugs is guided by the licensed provider's medical judgment, which is informed by a telehealth consultation and medical history.

We encourage all prospective users of compounded medications to speak with their provider about the specific risks and benefits that may come with the use of compounded medication. Embody does not produce compounded medications, and individuals may receive medication that looks different than what is portrayed on the website.

Pharmacy Providers
We are partnered with multiple USA certified pharmacies to bring the best product and overall experience to our membership. Our team meets regularly with pharmacies to discuss any product shortages, shipping delays, and get updated reports on their medication testing.

*Results vary based on starting weight and program adherence. Inches lost from hips, waist, chest, thighs and arms in the first month. Patients exercised daily and ate a reduced-calorie diet. Their fat loss is not typical. Results may vary. Medication prescriptions are at the discretion of medical providers and may not be suitable for everyone. Embody patients typically result in 1-2 lbs per week weight loss after 4 weeks, involving a healthy diet and exercise changes. Consult a healthcare professional before using medication or starting any weight loss program. *Based on the average weight loss as reported by patients without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, along with a reduced-calorie diet and increased physical activity.

Medication is included in the cost of the Embody Program. Wegovy® is FDA-approved for weight loss. Ozempic® is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss. The trademarks, service marks, and trade names (Wegovy®, Ozempic®) displayed on this website are protected and belong to their respective owners. Medical treatment is provided by independent licensed providers. No data, photos, claims or any other information is associated with results derived from clinical trials, studies or public information and is always representative of Embody patient experience.

Certain materials on this website, including text, images, and other media, may be generated or enhanced using artificial intelligence technologies. No representation or warranty is made regarding the accuracy, completeness, or reliability of such content. Individuals appearing in advertisements may be actors or models.

Testimonials on the website are from Embody patients. For patient privacy, images representing those testimonials may use models.

By accepting our Terms of Use, you additionally understand and agree that Embody is not acting as a pharmacy, nor does Embody control or interfere with any such services. By accepting these Terms of Use, you understand and agree that you may be entering into a relationship with a pharmacy, pharmacist, and/or pharmacy group or other such relationship with any one or more such third-party entities. Prescriptions, if issued, are filled by licensed partner pharmacies.

Partner Pharmacies

© 2026 Embody. All rights reserved.

Terms & ConditionsPrivacy PolicyPrivacy PracticesRefund PolicyMedical ConsentFor California ResidentsBill of RightsSafety & Side EffectsTCPA Compliance Policy